Company intelligence / Profile preview

Myaderm

Denver, Colorado, United States

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Myaderm is a healthcare company that specializes in the development and commercialization of cannabidiol (CBD) based topical products using advanced transdermal delivery technology. The company focuses on providing fast-acting, clinical-grade solutions for pain management, inflammation, and dermatological conditions. Their product portfolio includes specialized creams for sports recovery, skin care, and general wellness, designed to be non-greasy and absorbed quickly through the skin. By utilizing pharmaceutical-grade ingredients and rigorous testing, Myaderm aims to bridge the gap between traditional medicine and cannabinoid-based therapies.

Therapeutic areas: RheumatologyImmunologyNeurologyDermatology
Modalities: Small moleculeTopical
Industry: Food & Nutrition

Beyond the preview

Go deeper on Myaderm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myaderm.

Explore the full profile